The specific enhancement of interferon alpha induced growth inhibition by BCR/ABL only occurs in multipotent cells

The Hematology Journal : the Official Journal of the European Haematology Association
A PierceE Spooncer

Abstract

The causative oncogene in CML is the BCR/ABL protein tyrosine kinase. This stem cell disease is often treated with interferon alpha (IFN-alpha) which can initiate haematological and cytological remission which is associated with increased survival. There is however no clear indication of why CML cells are more responsive to IFN-alpha. To establish if BCR/ABL increases the sensitivity of multipotent cells to IFN-alpha a temperature sensitive mutant of BCR/ABL was expressed in the multipotent haemopoietic stem cell line FDCP-Mix. The effect of IFN-alpha in terms of proliferation, induction of apoptosis, changes in cell cycle inhibitor proteins, and differentiation was assessed by [3H]thymidine incorporation, Annexin V and Western blot analysis. When the BCR/ABL tyrosine kinase was activated, the IFN-alpha-induced inhibition on the growth rate of the FDCP-Mix cell population was more marked than in control populations. The BCR/ABL-mediated effect was due to decreased rates of DNA synthesis. There was no IFN-alpha-mediated induction of apoptosis. This enhanced BCR/ABL mediated growth inhibition occurred over a range of growth factor concentrations and was independent of changes in p21(Cip1) and p27(Kip) levels. When FDCP-Mix cells ...Continue Reading

Citations

Sep 10, 2005·Blood·Carol Ann HuffRichard J Jones
Apr 1, 2008·British Journal of Haematology·Andrew PierceAnthony D Whetton
Apr 22, 2004·Journal of the National Cancer Institute·Richard J JonesB Douglas Smith
Dec 4, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Edgar FaberKarel Indrak
Dec 24, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Edgar FaberUNKNOWN Cooperating Group
Nov 6, 2004·Blood·Lucy J ElrickTessa L Holyoake
Jul 27, 2005·British Journal of Haematology·Greg R AngstreichRichard J Jones
Apr 13, 2004·Current Opinion in Oncology·Greg R AngstreichRichard J Jones
Apr 29, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carol Ann HuffRichard J Jones
Jan 18, 2011·Journal of Experimental & Clinical Cancer Research : CR·Bing LongWentong Meng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.